{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:32:43Z","timestamp":1791232363260,"version":"4.1.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T00:00:00Z","timestamp":1276128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T00:00:00Z","timestamp":1276128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/gene.2010.35","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T09:15:56Z","timestamp":1276161356000},"page":"599-608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Mast cell homeostasis and the JAK\u2013STAT pathway"],"prefix":"10.1038","volume":"11","author":[{"given":"J K","family":"Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y T","family":"Falanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Depcrynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,10]]},"reference":[{"key":"BFgene201035_CR1","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ni.f.216","volume":"9","author":"J Kalesnikoff","year":"2008","unstructured":"Kalesnikoff J, Galli SJ . New developments in mast cell biology. Nat Immunol 2008; 9: 1215\u20131223.","journal-title":"Nat Immunol"},{"key":"BFgene201035_CR2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1101\/gad.2.4.383","volume":"2","author":"DE Levy","year":"1988","unstructured":"Levy DE, Kessler DS, Pine R, Reich N, Darnell Jr JE . Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev 1988; 2: 383\u2013393.","journal-title":"Genes Dev"},{"key":"BFgene201035_CR3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/j.1460-2075.1988.tb02872.x","volume":"7","author":"MN Rutherford","year":"1988","unstructured":"Rutherford MN, Hannigan GE, Williams BR . Interferon-induced binding of nuclear factors to promoter elements of the 2\u20135A synthetase gene. EMBO J 1988; 7: 751\u2013759.","journal-title":"EMBO J"},{"key":"BFgene201035_CR4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1496401","volume":"257","author":"C Schindler","year":"1992","unstructured":"Schindler C, Shuai K, Prezioso VR, Darnell Jr JE . Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 1992; 257: 809\u2013813.","journal-title":"Science"},{"key":"BFgene201035_CR5","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1126\/science.1281555","volume":"258","author":"K Shuai","year":"1992","unstructured":"Shuai K, Schindler C, Prezioso VR, Darnell Jr JE . Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 1992; 258: 1808\u20131812.","journal-title":"Science"},{"key":"BFgene201035_CR6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0092-8674(92)90105-L","volume":"70","author":"L Velazquez","year":"1992","unstructured":"Velazquez L, Fellous M, Stark GR, Pellegrini S . A protein tyrosine kinase in the interferon alpha\/beta signaling pathway. Cell 1992; 70: 313\u2013322.","journal-title":"Cell"},{"key":"BFgene201035_CR7","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1182\/blood-2002-11-3490","volume":"102","author":"CP Shelburne","year":"2003","unstructured":"Shelburne CP, McCoy ME, Piekorz R, Sexl V, Roh KH, Jacobs-Helber SM et al. Stat5 expression is critical for mast cell development and survival. Blood 2003; 102: 1290\u20131297.","journal-title":"Blood"},{"key":"BFgene201035_CR8","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0161-5890(02)00061-5","volume":"38","author":"CP Shelburne","year":"2002","unstructured":"Shelburne CP, McCoy ME, Piekorz R, Sexl VV, Gillespie SR, Bailey DP et al. Stat5: an essential regulator of mast cell biology. Mol Immunol 2002; 38: 1187\u20131191.","journal-title":"Mol Immunol"},{"key":"BFgene201035_CR9","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","volume":"264","author":"JE Darnell","year":"1994","unstructured":"Darnell JE, Kerr IM, Stark GR . Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415\u20131421.","journal-title":"Science"},{"key":"BFgene201035_CR10","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1226","volume":"3","author":"K Shuai","year":"2003","unstructured":"Shuai K, Liu B . Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 2003; 3: 900\u2013911.","journal-title":"Nat Rev Immunol"},{"key":"BFgene201035_CR11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","volume":"3","author":"DE Levy","year":"2002","unstructured":"Levy DE, Darnell Jr JE . Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002; 3: 651\u2013662.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFgene201035_CR12","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","volume":"277","author":"JE Darnell Jr","year":"1997","unstructured":"Darnell Jr JE . STATs and gene regulation. Science 1997; 277: 1630\u20131635.","journal-title":"Science"},{"key":"BFgene201035_CR13","first-page":"1347","volume":"7","author":"AG Harpur","year":"1992","unstructured":"Harpur AG, Andres AC, Ziemiecki A, Aston RR, Wilks AF . JAK2, a third member of the JAK family of protein tyrosine kinases. Oncogene 1992; 7: 1347\u20131353.","journal-title":"Oncogene"},{"key":"BFgene201035_CR14","first-page":"2057","volume":"11","author":"AF Wilks","year":"1991","unstructured":"Wilks AF, Harpur AG, Kurban RR, Ralph SJ, Zurcher G, Ziemiecki A . Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol Cell Biol 1991; 11: 2057\u20132065.","journal-title":"Mol Cell Biol"},{"key":"BFgene201035_CR15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/protein\/15.9.727","volume":"15","author":"F Giordanetto","year":"2002","unstructured":"Giordanetto F, Kroemer RT . Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7. Protein Eng 2002; 15: 727\u2013737.","journal-title":"Protein Eng"},{"key":"BFgene201035_CR16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0092-8674(94)90357-3","volume":"76","author":"K Shuai","year":"1994","unstructured":"Shuai K, Horvath CM, Huang LH, Qureshi SA, Cowburn D, Darnell Jr JE . Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 1994; 76: 821\u2013828.","journal-title":"Cell"},{"key":"BFgene201035_CR17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0092-8674(93)90734-8","volume":"74","author":"XY Fu","year":"1993","unstructured":"Fu XY, Zhang JJ . Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter. Cell 1993; 74: 1135\u20131145.","journal-title":"Cell"},{"key":"BFgene201035_CR18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semcdb.2008.08.010","volume":"19","author":"C Schindler","year":"2008","unstructured":"Schindler C, Plumlee C . Inteferons pen the JAK-STAT pathway. Semin Cell Dev Biol 2008; 19: 311\u2013318.","journal-title":"Semin Cell Dev Biol"},{"key":"BFgene201035_CR19","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1126\/science.7690989","volume":"261","author":"K Shuai","year":"1993","unstructured":"Shuai K, Stark GR, Kerr IM, Darnell Jr JE . A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 1993; 261: 1744\u20131746.","journal-title":"Science"},{"key":"BFgene201035_CR20","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1128\/MCB.16.9.4932","volume":"16","author":"K Shuai","year":"1996","unstructured":"Shuai K, Liao J, Song MM . Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1. Mol Cell Biol 1996; 16: 4932\u20134941.","journal-title":"Mol Cell Biol"},{"key":"BFgene201035_CR21","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.273.5276.794","volume":"273","author":"X Xu","year":"1996","unstructured":"Xu X, Sun YL, Hoey T . Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 1996; 273: 794\u2013797.","journal-title":"Science"},{"key":"BFgene201035_CR22","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1002\/j.1460-2075.1993.tb06106.x","volume":"12","author":"M Muller","year":"1993","unstructured":"Muller M, Laxton C, Briscoe J, Schindler C, Improta T, Darnell JE et al. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J 1993; 12: 4221\u20134228.","journal-title":"EMBO J"},{"key":"BFgene201035_CR23","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.2337\/diabetes.51.11.3311","volume":"51","author":"MF Brizzi","year":"2002","unstructured":"Brizzi MF, Dentelli P, Gambino R, Cabodi S, Cassader M, Castelli A et al. STAT5 activation induced by diabetic LDL depends on LDL glycation and occurs via src kinase activity. Diabetes 2002; 51: 3311\u20133317.","journal-title":"Diabetes"},{"key":"BFgene201035_CR24","first-page":"357","volume":"25","author":"JJ Ryan","year":"1997","unstructured":"Ryan JJ, Huang H, McReynolds LJ, Shelburne C, Hu-Li J, Huff TF et al. Stem cell factor activates STAT-5 DNA binding in IL-3-derived bone marrow mast cells. Exp Hematol 1997; 25: 357\u2013362.","journal-title":"Exp Hematol"},{"key":"BFgene201035_CR25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1182\/blood.V88.1.138.138","volume":"88","author":"A Gotoh","year":"1996","unstructured":"Gotoh A, Takahira H, Mantel C, Litz-Jackson S, Boswell HS, Broxmeyer HE . Steel factor induces serine phosphorylation of Stat3 in human growth factor-dependent myeloid cell lines. Blood 1996; 88: 138\u2013145.","journal-title":"Blood"},{"key":"BFgene201035_CR26","doi-asserted-by":"crossref","first-page":"16965","DOI":"10.1074\/jbc.274.24.16965","volume":"274","author":"MF Brizzi","year":"1999","unstructured":"Brizzi MF, Dentelli P, Rosso A, Yarden Y, Pegoraro L . STAT protein recruitment and activation in c-Kit deletion mutants. J Biol Chem 1999; 274: 16965\u201316972.","journal-title":"J Biol Chem"},{"key":"BFgene201035_CR27","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2004-02-0631","volume":"104","author":"TR Hundley","year":"2004","unstructured":"Hundley TR, Gilfillan AM, Tkaczyk C, Andrade MV, Metcalfe DD, Beaven MA . Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 2004; 104: 2410\u20132417.","journal-title":"Blood"},{"key":"BFgene201035_CR28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/IR:34:2:97","volume":"34","author":"Y Okayama","year":"2006","unstructured":"Okayama Y, Kawakami T . Development, migration, and survival of mast cells. Immunol Res 2006; 34: 97\u2013115.","journal-title":"Immunol Res"},{"key":"BFgene201035_CR29","volume-title":"Fundamental Immunology","author":"WJ Leonard","year":"2003","unstructured":"Leonard WJ . Type I cytokines and interferons and their receptors. In: Paul WE (ed) Fundamental Immunology. 5th edn. Lippincott Williams and Wilkins: Philadelphia, 2003. p 701."},{"key":"BFgene201035_CR30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/32190","volume":"392","author":"CS Lantz","year":"1998","unstructured":"Lantz CS, Boesiger J, Song CH, Mach N, Kobayashi T, Mulligan RC et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998; 392: 90\u201393.","journal-title":"Nature"},{"key":"BFgene201035_CR31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cellsig.2004.06.004","volume":"17","author":"R Shivakrupa","year":"2005","unstructured":"Shivakrupa R, Linnekin D . Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells. Cell Signal 2005; 17: 103\u2013109.","journal-title":"Cell Signal"},{"key":"BFgene201035_CR32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nri818","volume":"2","author":"WS Alexander","year":"2002","unstructured":"Alexander WS . Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2002; 2: 410\u2013416.","journal-title":"Nat Rev Immunol"},{"key":"BFgene201035_CR33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1189\/jlb.70.3.348","volume":"70","author":"CJ Greenhalgh","year":"2001","unstructured":"Greenhalgh CJ, Hilton DJ . Negative regulation of cytokine signaling. J Leukoc Biol 2001; 70: 348\u2013356.","journal-title":"J Leukoc Biol"},{"key":"BFgene201035_CR34","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/43206","volume":"387","author":"R Starr","year":"1997","unstructured":"Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ et al. A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387: 917\u2013921.","journal-title":"Nature"},{"key":"BFgene201035_CR35","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/43219","volume":"387","author":"T Naka","year":"1997","unstructured":"Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997; 387: 924\u2013929.","journal-title":"Nature"},{"key":"BFgene201035_CR36","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/43213","volume":"387","author":"TA Endo","year":"1997","unstructured":"Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997; 387: 921\u2013924.","journal-title":"Nature"},{"key":"BFgene201035_CR37","doi-asserted-by":"crossref","first-page":"29338","DOI":"10.1074\/jbc.M003456200","volume":"275","author":"A Sasaki","year":"2000","unstructured":"Sasaki A, Yasukawa H, Shouda T, Kitamura T, Dikic I, Yoshimura A . CIS3\/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J Biol Chem 2000; 275: 29338\u201329347.","journal-title":"J Biol Chem"},{"key":"BFgene201035_CR38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/emboj\/18.2.375","volume":"18","author":"SE Nicholson","year":"1999","unstructured":"Nicholson SE, Willson TA, Farley A, Starr R, Zhang JG, Baca M et al. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J 1999; 18: 375\u2013385.","journal-title":"EMBO J"},{"key":"BFgene201035_CR39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0092-8674(95)90311-9","volume":"82","author":"Z Wen","year":"1995","unstructured":"Wen Z, Zhong Z, Darnell Jr JE . Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995; 82: 241\u2013250.","journal-title":"Cell"},{"key":"BFgene201035_CR40","doi-asserted-by":"crossref","first-page":"13261","DOI":"10.1073\/pnas.231486498","volume":"98","author":"JG Zhang","year":"2001","unstructured":"Zhang JG, Metcalf D, Rakar S, Asimakis M, Greenhalgh CJ, Willson TA et al. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo. Proc Natl Acad Sci USA 2001; 98: 13261\u201313265.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgene201035_CR41","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1038\/sj.onc.1203481","volume":"19","author":"T Decker","year":"2000","unstructured":"Decker T, Kovarik P . Serine phosphorylation of STATs. Oncogene 2000; 19: 2628\u20132637.","journal-title":"Oncogene"},{"key":"BFgene201035_CR42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1039\/b606246f","volume":"2","author":"CP Lim","year":"2006","unstructured":"Lim CP, Cao X . Structure, function, and regulation of STAT proteins. Mol Biosyst 2006; 2: 536\u2013550.","journal-title":"Mol Biosyst"},{"key":"BFgene201035_CR43","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1128\/MCB.17.11.6618","volume":"17","author":"X Zhu","year":"1997","unstructured":"Zhu X, Wen Z, Xu LZ, Darnell Jr JE . Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol Cell Biol 1997; 17: 6618\u20136623.","journal-title":"Mol Cell Biol"},{"key":"BFgene201035_CR44","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1093\/emboj\/17.13.3660","volume":"17","author":"P Kovarik","year":"1998","unstructured":"Kovarik P, Stoiber D, Novy M, Decker T . Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation. EMBO J 1998; 17: 3660\u20133668.","journal-title":"EMBO J"},{"key":"BFgene201035_CR45","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/jvi.70.1.647-650.1996","volume":"70","author":"CM Horvath","year":"1996","unstructured":"Horvath CM, Darnell Jr JE . The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein. J Virol 1996; 70: 647\u2013650.","journal-title":"J Virol"},{"key":"BFgene201035_CR46","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1128\/MCB.17.11.6508","volume":"17","author":"J Chung","year":"1997","unstructured":"Chung J, Uchida E, Grammer TC, Blenis J . STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 1997; 17: 6508\u20136516.","journal-title":"Mol Cell Biol"},{"issue":"Part 1","key":"BFgene201035_CR47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/bj3470089","volume":"347","author":"JJ Schuringa","year":"2000","unstructured":"Schuringa JJ, Jonk LJ, Dokter WH, Vellenga E, Kruijer W . Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1\/MKK-4 as signal transduction components. Biochem J 2000; 347 (Part 1): 89\u201396.","journal-title":"Biochem J"},{"key":"BFgene201035_CR48","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/MCB.22.14.5222-5234.2002","volume":"22","author":"N Kotaja","year":"2002","unstructured":"Kotaja N, Karvonen U, Janne OA, Palvimo JJ . PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol Cell Biol 2002; 22: 5222\u20135234.","journal-title":"Mol Cell Biol"},{"key":"BFgene201035_CR49","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"Q Li","year":"2002","unstructured":"Li Q, Verma IM . NF-kappaB regulation in the immune system. Nat Rev Immunol 2002; 2: 725\u2013734.","journal-title":"Nat Rev Immunol"},{"key":"BFgene201035_CR50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1074-7613(02)00449-1","volume":"17","author":"R Nakagawa","year":"2002","unstructured":"Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A, Abe T et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002; 17: 677\u2013687.","journal-title":"Immunity"},{"key":"BFgene201035_CR51","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.immuni.2005.04.008","volume":"22","author":"T Tanaka","year":"2005","unstructured":"Tanaka T, Soriano MA, Grusby MJ . SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling. Immunity 2005; 22: 729\u2013736.","journal-title":"Immunity"},{"key":"BFgene201035_CR52","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.4049\/jimmunol.162.5.2703","volume":"162","author":"MA Sherman","year":"1999","unstructured":"Sherman MA, Secor VH, Brown MA . IL-4 preferentially activates a novel STAT6 isoform in mast cells. J Immunol 1999; 162: 2703\u20132708.","journal-title":"J Immunol"},{"key":"BFgene201035_CR53","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.bbrc.2003.08.067","volume":"309","author":"K Suzuki","year":"2003","unstructured":"Suzuki K, Nakajima H, Ikeda K, Tamachi T, Hiwasa T, Saito Y et al. Stat6-protease but not Stat5-protease is inhibited by an elastase inhibitor ONO-5046. Biochem Biophys Res Commun 2003; 309: 768\u2013773.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgene201035_CR54","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/cyto.2002.1957","volume":"19","author":"CP Shelburne","year":"2002","unstructured":"Shelburne CP, Piekorz RP, Bouton LA, Chong HJ, Ryan JJ . Mast cell-restricted p70 Stat6 isoform is a product of selective proteolysis. Cytokine 2002; 19: 218\u2013227.","journal-title":"Cytokine"},{"key":"BFgene201035_CR55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(00)81013-2","volume":"98","author":"M Socolovsky","year":"1999","unstructured":"Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF . Fetal anemia and apoptosis of red cell progenitors in Stat5a\u2212\/\u22125b\u2212\/\u2212 mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 1999; 98: 181\u2013191.","journal-title":"Cell"},{"key":"BFgene201035_CR56","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1038\/sj.onc.1205942","volume":"21","author":"S Xie","year":"2002","unstructured":"Xie S, Lin H, Sun T, Arlinghaus RB . Jak2 is involved in c-Myc induction by Bcr-Abl. Oncogene 2002; 21: 7137\u20137146.","journal-title":"Oncogene"},{"key":"BFgene201035_CR57","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaci.2007.01.004","volume":"119","author":"W Chen","year":"2007","unstructured":"Chen W, Khurana Hershey GK . Signal transducer and activator of transcription signals in allergic disease. J Allergy Clin Immunol 2007; 119: 529\u2013541; quiz 542-543.","journal-title":"J Allergy Clin Immunol"},{"key":"BFgene201035_CR58","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1084\/jem.183.3.811","volume":"183","author":"N Carlesso","year":"1996","unstructured":"Carlesso N, Frank DA, Griffin JD . Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr\/Abl. J Exp Med 1996; 183: 811\u2013820.","journal-title":"J Exp Med"},{"key":"BFgene201035_CR59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbrc.2004.06.126","volume":"321","author":"H Sasanuma","year":"2004","unstructured":"Sasanuma H, Tatsuno A, Tsuji K, Hidano S, Morita S, Kitamura T et al. Transcriptional regulation of SLP-76 family hematopoietic cell adaptor MIST\/Clnk by STAT5. Biochem Biophys Res Commun 2004; 321: 145\u2013153.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgene201035_CR60","doi-asserted-by":"crossref","first-page":"30264","DOI":"10.1074\/jbc.270.51.30264","volume":"270","author":"DC Look","year":"1995","unstructured":"Look DC, Pelletier MR, Tidwell RM, Roswit WT, Holtzman MJ . Stat1 depends on transcriptional synergy with Sp1. J Biol Chem 1995; 270: 30264\u201330267.","journal-title":"J Biol Chem"},{"key":"BFgene201035_CR61","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1073\/pnas.92.20.9097","volume":"92","author":"TS Schaefer","year":"1995","unstructured":"Schaefer TS, Sanders LK, Nathans D . Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. Proc Natl Acad Sci USA 1995; 92: 9097\u20139101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgene201035_CR62","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/383344a0","volume":"383","author":"S Bhattacharya","year":"1996","unstructured":"Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D\u2019Andrea A et al. Cooperation of Stat2 and p300\/CBP in signalling induced by interferon-alpha. Nature 1996; 383: 344\u2013347.","journal-title":"Nature"},{"key":"BFgene201035_CR63","doi-asserted-by":"crossref","first-page":"15092","DOI":"10.1073\/pnas.93.26.15092","volume":"93","author":"JJ Zhang","year":"1996","unstructured":"Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, Darnell Jr JE . Two contact regions between Stat1 and CBP\/p300 in interferon gamma signaling. Proc Natl Acad Sci USA 1996; 93: 15092\u201315096.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgene201035_CR64","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/nar\/27.13.2722","volume":"27","author":"S Gingras","year":"1999","unstructured":"Gingras S, Simard J, Groner B, Pfitzner E . p300\/CBP is required for transcriptional induction by interleukin-4 and interacts with Stat6. Nucleic Acids Res 1999; 27: 2722\u20132729.","journal-title":"Nucleic Acids Res"},{"key":"BFgene201035_CR65","doi-asserted-by":"crossref","first-page":"22165","DOI":"10.1074\/jbc.274.32.22165","volume":"274","author":"M Silva","year":"1999","unstructured":"Silva M, Benito A, Sanz C, Prosper F, Ekhterae D, Nunez G et al. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. J Biol Chem 1999; 274: 22165\u201322169.","journal-title":"J Biol Chem"},{"key":"BFgene201035_CR66","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1038\/sj.onc.1202796","volume":"18","author":"S Dumon","year":"1999","unstructured":"Dumon S, Santos SC, Debierre-Grockiego F, Gouilleux-Gruart V, Cocault L, Boucheron C et al. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Oncogene 1999; 18: 4191\u20134199.","journal-title":"Oncogene"},{"key":"BFgene201035_CR67","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","volume":"10","author":"R Catlett-Falcone","year":"1999","unstructured":"Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999; 10: 105\u2013115.","journal-title":"Immunity"},{"key":"BFgene201035_CR68","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.191.6.977","volume":"191","author":"M Horita","year":"2000","unstructured":"Horita M, Andreu EJ, Benito A, Arbona C, Sanz C, Benet I et al. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL. J Exp Med 2000; 191: 977\u2013984.","journal-title":"J Exp Med"},{"key":"BFgene201035_CR69","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1011083031272","volume":"21","author":"YA Mekori","year":"2001","unstructured":"Mekori YA, Gilfillan AM, Akin C, Hartmann K, Metcalfe DD . Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL. J Clin Immunol 2001; 21: 171\u2013174.","journal-title":"J Clin Immunol"},{"key":"BFgene201035_CR70","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-2567.1997.00214.x","volume":"90","author":"YA Mekori","year":"1997","unstructured":"Mekori YA, Oh CK, Dastych J, Goff JP, Adachi S, Bianchine PJ et al. Characterization of a mast cell line that lacks the extracellular domain of membrane c-kit. Immunology 1997; 90: 518\u2013525.","journal-title":"Immunology"},{"issue":"Suppl 1","key":"BFgene201035_CR71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000085431","volume":"137","author":"K Ikeda","year":"2005","unstructured":"Ikeda K, Nakajima H, Suzuki K, Watanabe N, Kagami S, Iwamoto I . Stat5a is essential for the proliferation and survival of murine mast cells. Int Arch Allergy Immunol 2005; 137 (Suppl 1): 45\u201350.","journal-title":"Int Arch Allergy Immunol"},{"key":"BFgene201035_CR72","doi-asserted-by":"crossref","first-page":"26107","DOI":"10.1074\/jbc.M011475200","volume":"276","author":"A Masuda","year":"2001","unstructured":"Masuda A, Matsuguchi T, Yamaki K, Hayakawa T, Yoshikai Y . Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression. J Biol Chem 2001; 276: 26107\u201326113.","journal-title":"J Biol Chem"},{"key":"BFgene201035_CR73","first-page":"945","volume":"8","author":"R Buettner","year":"2002","unstructured":"Buettner R, Mora LB, Jove R . Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 2002; 8: 945\u2013954.","journal-title":"Clin Cancer Res"},{"key":"BFgene201035_CR74","doi-asserted-by":"crossref","first-page":"31574","DOI":"10.1074\/jbc.M303499200","volume":"278","author":"S Xi","year":"2003","unstructured":"Xi S, Zhang Q, Dyer KF, Lerner EC, Smithgall TE, Gooding WE et al. Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck. J Biol Chem 2003; 278: 31574\u201331583.","journal-title":"J Biol Chem"},{"key":"BFgene201035_CR75","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.4049\/jimmunol.173.10.6409","volume":"173","author":"BA Stout","year":"2004","unstructured":"Stout BA, Bates ME, Liu LY, Farrington NN, Bertics PJ . IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils. J Immunol 2004; 173: 6409\u20136417.","journal-title":"J Immunol"},{"key":"BFgene201035_CR76","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJM200101043440106","volume":"344","author":"AB Kay","year":"2001","unstructured":"Kay AB . Allergy and allergic diseases. First of two parts. N Engl J Med 2001; 344: 30\u201337.","journal-title":"N Engl J Med"},{"key":"BFgene201035_CR77","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1172\/JCI0215786","volume":"109","author":"AB Pernis","year":"2002","unstructured":"Pernis AB, Rothman PB . JAK-STAT signaling in asthma. J Clin Invest 2002; 109: 1279\u20131283.","journal-title":"J Clin Invest"},{"key":"BFgene201035_CR78","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nri2018","volume":"7","author":"SC Bischoff","year":"2007","unstructured":"Bischoff SC . Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007; 7: 93\u2013104.","journal-title":"Nat Rev Immunol"},{"key":"BFgene201035_CR79","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI0215770","volume":"109","author":"T Decker","year":"2002","unstructured":"Decker T, Stockinger S, Karaghiosoff M, Muller M, Kovarik P . IFNs and STATs in innate immunity to microorganisms. J Clin Invest 2002; 109: 1271\u20131277.","journal-title":"J Clin Invest"},{"key":"BFgene201035_CR80","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/382174a0","volume":"382","author":"MH Kaplan","year":"1996","unstructured":"Kaplan MH, Sun YL, Hoey T, Grusby MJ . Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1996; 382: 174\u2013177.","journal-title":"Nature"},{"key":"BFgene201035_CR81","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/380627a0","volume":"380","author":"K Takeda","year":"1996","unstructured":"Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S et al. Essential role of Stat6 in IL-4 signalling. Nature 1996; 380: 627\u2013630.","journal-title":"Nature"},{"key":"BFgene201035_CR82","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.4049\/jimmunol.177.5.3421","volume":"177","author":"BO Barnstein","year":"2006","unstructured":"Barnstein BO, Li G, Wang Z, Kennedy S, Chalfant C, Nakajima H et al. Stat5 expression is required for IgE-mediated mast cell function. J Immunol 2006; 177: 3421\u20133426.","journal-title":"J Immunol"},{"key":"BFgene201035_CR83","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1084\/jem.193.9.1087","volume":"193","author":"A Mathew","year":"2001","unstructured":"Mathew A, MacLean JA, DeHaan E, Tager AM, Green FH, Luster AD . Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med 2001; 193: 1087\u20131096.","journal-title":"J Exp Med"},{"key":"BFgene201035_CR84","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.64.1.2","volume":"64","author":"MH Kaplan","year":"1998","unstructured":"Kaplan MH, Grusby MJ . Regulation of T helper cell differentiation by STAT molecules. J Leukoc Biol 1998; 64: 2\u20135.","journal-title":"J Leukoc Biol"},{"key":"BFgene201035_CR85","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.187.9.1537","volume":"187","author":"T Akimoto","year":"1998","unstructured":"Akimoto T, Numata F, Tamura M, Takata Y, Higashida N, Takashi T et al. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice. J Exp Med 1998; 187: 1537\u20131542.","journal-title":"J Exp Med"},{"key":"BFgene201035_CR86","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2222.1999.00405.x","volume":"29","author":"S Miyata","year":"1999","unstructured":"Miyata S, Matsuyama T, Kodama T, Nishioka Y, Kuribayashi K, Takeda K et al. STAT6 deficiency in a mouse model of allergen-induced airways inflammation abolishes eosinophilia but induces infiltration of CD8+ T cells. Clin Exp Allergy 1999; 29: 114\u2013123.","journal-title":"Clin Exp Allergy"},{"key":"BFgene201035_CR87","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114: 937\u2013951.","journal-title":"Blood"},{"key":"BFgene201035_CR88","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","volume":"112","author":"DD Metcalfe","year":"2008","unstructured":"Metcalfe DD . Mast cells and mastocytosis. Blood 2008; 112: 946\u2013956.","journal-title":"Blood"},{"key":"BFgene201035_CR89","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","volume":"113","author":"KH Lim","year":"2009","unstructured":"Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009; 113: 5727\u20135736.","journal-title":"Blood"},{"key":"BFgene201035_CR90","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2141.2009.07870.x","volume":"147","author":"LF Grimwade","year":"2009","unstructured":"Grimwade LF, Happerfield L, Tristram C, McIntosh G, Rees M, Bench AJ et al. Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms. Br J Haematol 2009; 147: 495\u2013506.","journal-title":"Br J Haematol"},{"key":"BFgene201035_CR91","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144\u20131148.","journal-title":"Nature"},{"key":"BFgene201035_CR92","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1128\/MCB.17.3.1562","volume":"17","author":"H Luo","year":"1997","unstructured":"Luo H, Rose P, Barber D, Hanratty WP, Lee S, Roberts TM et al. Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol Cell Biol 1997; 17: 1562\u20131571.","journal-title":"Mol Cell Biol"},{"key":"BFgene201035_CR93","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779\u20131790.","journal-title":"N Engl J Med"},{"key":"BFgene201035_CR94","doi-asserted-by":"crossref","first-page":"18177","DOI":"10.1074\/jbc.M600064200","volume":"281","author":"C Walz","year":"2006","unstructured":"Walz C, Crowley BJ, Hudon HE, Gramlich JL, Neuberg DS, Podar K et al. Activated Jak2 with the V617F point mutation promotes G1\/S phase transition. J Biol Chem 2006; 281: 18177\u201318183.","journal-title":"J Biol Chem"},{"key":"BFgene201035_CR95","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood-2007-09-115477","volume":"112","author":"N Harir","year":"2008","unstructured":"Harir N, Boudot C, Friedbichler K, Sonneck K, Kondo R, Martin-Lanneree S et al. Oncogenic Kit controls neoplastic mast cell growth through a Stat5\/PI3-kinase signaling cascade. Blood 2008; 112: 2463\u20132473.","journal-title":"Blood"},{"key":"BFgene201035_CR96","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","volume":"9","author":"JA Engelman","year":"2009","unstructured":"Engelman JA . Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 2009; 9: 550\u2013562.","journal-title":"Nat Rev Cancer"},{"key":"BFgene201035_CR97","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cellsig.2008.11.008","volume":"21","author":"M Pedersen","year":"2009","unstructured":"Pedersen M, Ronnstrand L, Sun J . The c-Kit\/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit. Cell Signal 2009; 21: 413\u2013418.","journal-title":"Cell Signal"},{"key":"BFgene201035_CR98","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","volume":"92","author":"T Furitsu","year":"1993","unstructured":"Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993; 92: 1736\u20131744.","journal-title":"J Clin Invest"},{"key":"BFgene201035_CR99","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","volume":"92","author":"H Nagata","year":"1995","unstructured":"Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995; 92: 10560\u201310564.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgene201035_CR100","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1074\/jbc.M808058200","volume":"284","author":"J Sun","year":"2009","unstructured":"Sun J, Pedersen M, Ronnstrand L . The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction. J Biol Chem 2009; 284: 11039\u201311047.","journal-title":"J Biol Chem"},{"key":"BFgene201035_CR101","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.2353\/ajpath.2009.080953","volume":"175","author":"C Baumgartner","year":"2009","unstructured":"Baumgartner C, Cerny-Reiterer S, Sonneck K, Mayerhofer M, Gleixner KV, Fritz R et al. Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis. Subcellular distribution and role of the transforming oncoprotein KIT D816V. Am J Pathol 2009; 175: 2416\u20132429.","journal-title":"Am J Pathol"},{"key":"BFgene201035_CR102","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.clinthera.2007.11.005","volume":"29","author":"M Steinberg","year":"2007","unstructured":"Steinberg M . Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Clin Ther 2007; 29: 2289\u20132308.","journal-title":"Clin Ther"},{"key":"BFgene201035_CR103","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood-2005-10-3969","volume":"108","author":"NP Shah","year":"2006","unstructured":"Shah NP, Lee FY, Luo R, Jiang Y, Donker M, Akin C . Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis. Blood 2006; 108: 286\u2013291.","journal-title":"Blood"},{"key":"BFgene201035_CR104","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1158\/0008-5472.CAN-05-2050","volume":"66","author":"MM Schittenhelm","year":"2006","unstructured":"Schittenhelm MM, Shiraga S, Schroeder A, Corbin AS, Griffith D, Lee FY et al. Dasatinib (BMS-354825), a dual SRC\/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies. Cancer Res 2006; 66: 473\u2013481.","journal-title":"Cancer Res"},{"key":"BFgene201035_CR105","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/1078-0432.CCR-08-0366","volume":"14","author":"S Verstovsek","year":"2008","unstructured":"Verstovsek S, Tefferi A, Cortes J, O\u2019Brien S, Garcia-Manero G, Pardanani A et al. Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis. Clin Cancer Res 2008; 14: 3906\u20133915.","journal-title":"Clin Cancer Res"},{"key":"BFgene201035_CR106","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2005-07-3022","volume":"107","author":"KV Gleixner","year":"2006","unstructured":"Gleixner KV, Mayerhofer M, Aichberger KJ, Derdak S, Sonneck K, Bohm A et al. PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects. Blood 2006; 107: 752\u2013759.","journal-title":"Blood"},{"key":"BFgene201035_CR107","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3324\/haematol.11339","volume":"92","author":"KV Gleixner","year":"2007","unstructured":"Gleixner KV, Mayerhofer M, Sonneck K, Gruze A, Samorapoompichit P, Baumgartner C et al. Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT. Haematologica 2007; 92: 1451\u20131459.","journal-title":"Haematologica"},{"key":"BFgene201035_CR108","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/cncr.22931","volume":"110","author":"J El Fitori","year":"2007","unstructured":"El Fitori J, Su Y, Buchler P, Ludwig R, Giese NA, Buchler MW et al. PKC 412 small-molecule tyrosine kinase inhibitor: single-compound therapy for pancreatic cancer. Cancer 2007; 110: 1457\u20131468.","journal-title":"Cancer"},{"key":"BFgene201035_CR109","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1182\/blood-2006-07-032714","volume":"109","author":"KJ Aichberger","year":"2007","unstructured":"Aichberger KJ, Mayerhofer M, Gleixner KV, Krauth MT, Gruze A, Pickl WF et al. Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412. Blood 2007; 109: 3031\u20133041.","journal-title":"Blood"},{"key":"BFgene201035_CR110","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1182\/blood-2008-08-175190","volume":"114","author":"KJ Aichberger","year":"2009","unstructured":"Aichberger KJ, Gleixner KV, Mirkina I, Cerny-Reiterer S, Peter B, Ferenc V et al. Identification of pro-apoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs. Blood 2009; 114: 5342\u20135351.","journal-title":"Blood"},{"key":"BFgene201035_CR111","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/jnci\/djp216","volume":"101","author":"K Garber","year":"2009","unstructured":"Garber K . JAK2 inhibitors: not the next imatinib but researchers see other possibilities. J Natl Cancer Inst 2009; 101: 980\u2013982.","journal-title":"J Natl Cancer Inst"},{"key":"BFgene201035_CR112","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-065X.2008.00644.x","volume":"223","author":"M Pesu","year":"2008","unstructured":"Pesu M, Laurence A, Kishore N, Zwillich SH, Chan G, O\u2019Shea JJ . Therapeutic targeting of Janus kinases. Immunol Rev 2008; 223: 132\u2013142.","journal-title":"Immunol Rev"},{"key":"BFgene201035_CR113","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4049\/jimmunol.161.1.302","volume":"161","author":"LA Linehan","year":"1998","unstructured":"Linehan LA, Warren WD, Thompson PA, Grusby MJ, Berton MT . STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination. J Immunol 1998; 161: 302\u2013310.","journal-title":"J Immunol"},{"key":"BFgene201035_CR114","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4049\/jimmunol.152.3.1094","volume":"152","author":"J Punnonen","year":"1994","unstructured":"Punnonen J, de Vries JE . IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells. J Immunol 1994; 152: 1094\u20131102.","journal-title":"J Immunol"},{"key":"BFgene201035_CR115","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1073\/pnas.90.8.3730","volume":"90","author":"J Punnonen","year":"1993","unstructured":"Punnonen J, Aversa G, Cocks BG, McKenzie AN, Menon S, Zurawski G et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993; 90: 3730\u20133734.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgene201035_CR116","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1189\/jlb.0708448","volume":"85","author":"K Speiran","year":"2009","unstructured":"Speiran K, Bailey DP, Fernando J, Macey M, Barnstein B, Kolawole M et al. Endogenous suppression of mast cell development and survival by IL-4 and IL-10. J Leukoc Biol 2009; 85: 826\u2013836.","journal-title":"J Leukoc Biol"},{"key":"BFgene201035_CR117","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.4049\/jimmunol.163.5.2530","volume":"163","author":"P Mirmonsef","year":"1999","unstructured":"Mirmonsef P, Shelburne CP, Fitzhugh Yeatman C, Chong HJ, Ryan JJ . Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3\u2032-kinase. J Immunol 1999; 163: 2530\u20132539.","journal-title":"J Immunol"},{"key":"BFgene201035_CR118","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.4049\/jimmunol.172.5.3181","volume":"172","author":"SR Gillespie","year":"2004","unstructured":"Gillespie SR, DeMartino RR, Zhu J, Chong HJ, Ramirez C, Shelburne CP et al. IL-10 inhibits Fc epsilon RI expression in mouse mast cells. J Immunol 2004; 172: 3181\u20133188.","journal-title":"J Immunol"},{"key":"BFgene201035_CR119","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1189\/jlb.0405201","volume":"80","author":"DP Bailey","year":"2006","unstructured":"Bailey DP, Kashyap M, Bouton LA, Murray PJ, Ryan JJ . Interleukin-10 induces apoptosis in developing mast cells and macrophages. J Leukoc Biol 2006; 80: 581\u2013589.","journal-title":"J Leukoc Biol"},{"key":"BFgene201035_CR120","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.192.8.1093","volume":"192","author":"CF Yeatman","year":"2000","unstructured":"Yeatman CF, Jacobs-Helber SM, Mirmonsef P, Gillespie SR, Bouton LA, Collins HA et al. Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis. J Exp Med 2000; 192: 1093\u20131103.","journal-title":"J Exp Med"},{"key":"BFgene201035_CR121","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/eji.200526275","volume":"36","author":"ZQ Hu","year":"2006","unstructured":"Hu ZQ, Zhao WH, Shimamura T, Galli SJ . Interleukin-4-triggered, STAT6-dependent production of a factor that induces mouse mast cell apoptosis. Eur J Immunol 2006; 36: 1275\u20131284.","journal-title":"Eur J Immunol"},{"key":"BFgene201035_CR122","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.4049\/jimmunol.180.5.2848","volume":"180","author":"S Kennedy Norton","year":"2008","unstructured":"Kennedy Norton S, Barnstein B, Brenzovich J, Bailey DP, Kashyap M, Speiran K et al. IL-10 suppresses mast cell IgE receptor expression and signaling in vitro and in vivo. J Immunol 2008; 180: 2848\u20132854.","journal-title":"J Immunol"},{"key":"BFgene201035_CR123","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.4049\/jimmunol.181.10.7263","volume":"181","author":"W Zhao","year":"2008","unstructured":"Zhao W, Gomez G, Yu SH, Ryan JJ, Schwartz LB . TGF-beta1 attenuates mediator release and de novo Kit expression by human skin mast cells through a Smad-dependent pathway. J Immunol 2008; 181: 7263\u20137272.","journal-title":"J Immunol"},{"key":"BFgene201035_CR124","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.4049\/jimmunol.174.10.5987","volume":"174","author":"G Gomez","year":"2005","unstructured":"Gomez G, Ramirez CD, Rivera J, Patel M, Norozian F, Wright HV et al. TGF-beta 1 inhibits mast cell Fc epsilon RI expression. J Immunol 2005; 174: 5987\u20135993.","journal-title":"J Immunol"},{"key":"BFgene201035_CR125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1615\/CritRevImmunol.v27.i1.20","volume":"27","author":"JJ Ryan","year":"2007","unstructured":"Ryan JJ, Kashyap M, Bailey D, Kennedy S, Speiran K, Brenzovich J et al. Mast cell homeostasis: a fundamental aspect of allergic disease. Crit Rev Immunol 2007; 27: 15\u201332.","journal-title":"Crit Rev Immunol"},{"key":"BFgene201035_CR126","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.exphem.2005.07.001","volume":"33","author":"M Kashyap","year":"2005","unstructured":"Kashyap M, Bailey DP, Gomez G, Rivera J, Huff TF, Ryan JJ . TGF-beta1 inhibits late-stage mast cell maturation. Exp Hematol 2005; 33: 1281\u20131291.","journal-title":"Exp Hematol"},{"key":"BFgene201035_CR127","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/intimm\/dxp102","volume":"21","author":"T Kouro","year":"2009","unstructured":"Kouro T, Takatsu K . IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int Immunol 2009; 21: 1303\u20131309.","journal-title":"Int Immunol"},{"key":"BFgene201035_CR128","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.coi.2008.04.001","volume":"20","author":"K Takatsu","year":"2008","unstructured":"Takatsu K, Nakajima H . IL-5 and eosinophilia. Curr Opin Immunol 2008; 20: 288\u2013294.","journal-title":"Curr Opin Immunol"},{"key":"BFgene201035_CR129","first-page":"180","volume":"75","author":"M Paplinska","year":"2007","unstructured":"Paplinska M, Grubek-Jaworska H, Chazan R . Role of eotaxin in the pathophysiology of asthma. Pneumonol Alergol Pol 2007; 75: 180\u2013185.","journal-title":"Pneumonol Alergol Pol"},{"key":"BFgene201035_CR130","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/rr52","volume":"2","author":"DM Conroy","year":"2001","unstructured":"Conroy DM, Williams TJ . Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res 2001; 2: 150\u2013156.","journal-title":"Respir Res"},{"key":"BFgene201035_CR131","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1365-2222.2003.01827.x","volume":"33","author":"CE Brightling","year":"2003","unstructured":"Brightling CE, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID, Bradding P . Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma. Clin Exp Allergy 2003; 33: 1711\u20131716.","journal-title":"Clin Exp Allergy"},{"key":"BFgene201035_CR132","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMoa012705","volume":"346","author":"CE Brightling","year":"2002","unstructured":"Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID . Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346: 1699\u20131705.","journal-title":"N Engl J Med"}],"container-title":["Genes & Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gene201035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gene201035","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gene201035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T14:35:48Z","timestamp":1685630148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gene201035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,10]]},"references-count":132,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["BFgene201035"],"URL":"https:\/\/doi.org\/10.1038\/gene.2010.35","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,10]]},"assertion":[{"value":"14 April 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}